期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
Background Mental health problems (e.g., depression and anxiety) are among the most commonly reported comorbidities of HIV. Antiretroviral therapy (AR......
期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
Background HIV pre-exposure prophylaxis (PrEP) is a key component of HIV combination prevention strategies and has the potential to decrease the incid......
期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
The widely-expressed molecule CD38 is a single-stranded type II transmembrane glycoprotein that is mainly involved in regulating the differentiation a......
期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
Background We estimated the predictive effects of ART-related perceptions on the actual ART uptake behavior among ART naive PLWH stratified by differe......
期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
Background Integrase inhibitors (INIs)-based antiretroviral therapies (ART) are more recommended than efavirenz (EFV)-based ART for people living with......
期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
BackgroundHIV testing and early linkage to care are critical for reducing the risk of HIV transmission. HIV self-testing (HIVST) is a useful tool for ......
期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
Background Peer education and HIV risk perception are related to HIV testing uptake among key populations. We aimed to examine the association between......
期刊： AIDS RESEARCH AND THERAPY, 2021; 18 (1)
Background Highly active antiretroviral therapy (ART) is still the only effective method to stop the disease progression in acquired immunodeficiency ......
期刊： AIDS RESEARCH AND THERAPY, 2020; 17 (1)
Objectives For migrant female sex workers (FSWs) at the Sino-Vietnamese border, the impact of work time in their current location on the spread of HIV......
期刊： AIDS RESEARCH AND THERAPY, 2020; 17 (1)
Background Antiretroviral adherence is essential to HIV treatment efficacy. Various self-reported measures are commonly used for assessing antiretrovi......
期刊： AIDS RESEARCH AND THERAPY, 2020; 17 (1)
Background The aim of this study was to assess trends in drug resistance and associated clinical and programmatic factors at a national level during t......
期刊： AIDS RESEARCH AND THERAPY, 2020; 17 (1)
The gut microbiota is emerging as a prominent player in maintaining health through several metabolic and immune pathways. Dysregulation of gut microbi......
期刊： AIDS RESEARCH AND THERAPY, 2020; 17 (1)
Background Increased intestinal barrier permeability and subsequent gut microbial translocation are significant contributors to inflammatory non-AIDS ......
期刊： AIDS RESEARCH AND THERAPY, 2020; 17 (1)
Background The anti-retroviral combination of abacavir/lamivudine plus rilpivirine (ABC/3TC/RPV) is not recommended by international guidelines as the......
期刊： AIDS RESEARCH AND THERAPY, 2020; 17 (1)
Background The clinical and laboratory characteristics of AIDS-associated Talaromyces marneffei infection, a rare but a fatal mycosis disease of the c......
